FOXP3 and cancer: The marked increase in CD4+FoxP3+ Treg levels in TT compared to NT and peripheral blood of CRC patients in our study was in accordance with previously published reports from other groups, where an expansion in Treg levels in TILs in various cancers including CRC was demonstrated (23, 26, 33).